## EFX: Equifax Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 0.2% below STRENGTH zone (3.0-6.0%); PEG 1.02 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($213.16)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. (EFX) Movement as an Input in Quant Signal Sets**
- Source: Stock Traders Daily | 20251229T024400 | Neutral | Relevance: 100%
- This article, published by Stock Traders Daily, analyzes Equifax Inc. (NYSE: EFX) using AI-driven quantitative signals. It highlights a mixed sentiment alignment indicating choppy conditions, and details three distinct trading strategies: a Long Position Trading Strategy, a Momentum Breakout Strategy, and a Risk Hedging Short Strategy. The analysis also provides multi-timeframe signal analysis with support and resistance levels.

**2. Assenagon Asset Management S.A. Decreases Stock Holdings in Equifax, Inc. $EFX**
- Source: MarketBeat | 20251227T000846 | Somewhat-Bearish | Relevance: 100%
- Assenagon Asset Management S.A. significantly reduced its stake in Equifax, Inc. (NYSE:EFX) by 94.5% in the third quarter, selling 49,030 shares and retaining 2,836 shares valued at $728,000. This comes amidst other institutional investors adjusting their positions and company insiders, including CEO Mark Begor, selling a total of 54,270 shares worth approximately $12.6 million in the last 90 days. Despite these sales, Equifax recently beat Q3 earnings estimates, issued strong FY2025 guidance, and holds a consensus "Moderate Buy" rating from analysts with an average target price of $274.73.

**3. Canoe Financial LP Buys 4,812 Shares of Equifax, Inc. $EFX**
- Source: MarketBeat | 20251227T090811 | Somewhat-Bullish | Relevance: 100%
- Canoe Financial LP increased its stake in Equifax, Inc. (NYSE: EFX) by 60.8% in the third quarter, purchasing an additional 4,812 shares to now own 12,729 shares valued at $3.27 million. Despite high institutional ownership (96.20%), insiders have been net sellers, with the CEO and EVP recently offloading significant shares. Equifax surpassed Q3 EPS estimates and provided strong FY2025 guidance, leading to a consensus "Moderate Buy" rating from analysts with an average price target of $274.73 against a current trading price of approximately $220.56.

**4. Osaic Holdings Inc. Raises Position in TransUnion $TRU**
- Source: MarketBeat | 20251228T130903 | Somewhat-Bullish | Relevance: 64%
- Osaic Holdings Inc. significantly increased its stake in TransUnion by 102.1% in Q2, now owning 25,970 shares valued at $2.22 million. This move aligns with broader institutional accumulation, as other firms like The Manufacturers Life Insurance Company and Northern Right Capital Management also boosted their positions. TransUnion recently exceeded Q3 earnings and revenue estimates and has an average analyst target of $103.54 with a "Moderate Buy" consensus.

**5. FTC delay derails Veriskâ€“AccuLynx deal and prompts $1.5B note buyback**
- Source: Stock Titan | 20251229T134657 | Neutral | Relevance: 52%
- Verisk (Nasdaq: VRSK) has terminated its agreement to acquire AccuLynx because the Federal Trade Commission did not complete its review by the contractual deadline. Consequently, Verisk will redeem $1.50 billion in senior notes issued for the acquisition at 101% of principal plus accrued interest. AccuLynx disputes the termination, but Verisk intends to defend its position.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $280 | $290 | -3% |
| 2025-12-08 | BMO Capital | $234 | $245 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Overweight |
| 2025-12-08 | BMO Capital | main | Market Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.86M) |
| Sells | 5 ($1.53M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 53.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+2.1%)
- Capital Internationa: 8.5% (-0.4%)
- Blackrock Inc.: 7.5% (+1.4%)
- Price (T.Rowe) Assoc: 4.9% (+1.0%)
- Harris Associates L.: 4.8% (+14.2%)

### Key Risks

1. Long-term trend broken: trading 8.1% below SMA200.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.02 suggests fair value with growth premium. Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $27.4B |
| Beta | 1.59 |
| 52W Range | $199.98 - $281.07 |
| Short Interest | 3.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.02 |
| Forward P/E | 25.2 |
| Current P/E | 29.2 |
| YoY Growth | 15.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at 0.2% (minimal 5-day change). Below STRENGTH zone by 2.8pp (needs >3.0% for momentum thesis). MRS_5 at 0.7% confirms short-term momentum alignment. Below SMA200 (0.92x), long-term trend not supportive. MACD histogram positive (0.85), confirming momentum. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.25% (CS: 72) | Neutral |
| RSI_14 | 61.2 | Neutral |
| MACD Histogram | 0.85 | Bullish |
| vs SMA20 | 1.027x | Above |
| vs SMA50 | 1.032x | Above |
| vs SMA200 | 0.919x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $222.10
- **Stop Loss:** $213.16 (4.0% risk)
- **Target:** $231.04 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 154
- **Position Value:** $34,203.40
- **Portfolio %:** 34.20%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite and defensive rotation. VIX at 14.2 (2nd percentile) signals low volatility, while positive yield curve (+58bps) and stable economic indicators support continued expansion. Market breadth at 58.7% shows decent participation, but rotation into defensive names and Fed liquidity concerns warrant measured positioning.*

### Earnings

**Next:** 2026-02-05 (Est: $2.04)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.94 | $2.04 | +5.3% |
| 2025Q2 | $1.92 | $2.00 | +4.1% |
| 2025Q1 | $1.40 | $1.53 | +9.0% |
| 2024Q4 | $2.10 | $2.12 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*